When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
CERS - Cerus bags $11M FDA contract to treat whole blood; shares +5%
Cerus Corporation
Cerus (CERS) ha been awarded a five-year contract valued at $11.1M with the FDA for the development of next-generation compounds to optimize pathogen reduction ((PR)) treatment of whole blood to reduce the risk of transfusion-transmitted infections. Pathogen reduced whole blood has the potential to fundamentally reshape the support of patients with massive hemorrhage.Shares up 5% premarket.